ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CBF Cobra Bio-Man.

2.25
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cobra Bio-Man. LSE:CBF London Ordinary Share GB0031704835 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.25 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Cobra Bio-manufacturing Share Discussion Threads

Showing 5601 to 5623 of 5900 messages
Chat Pages: 236  235  234  233  232  231  230  229  228  227  226  225  Older
DateSubjectAuthorDiscuss
07/4/2009
10:02
Does anyone have a 'fair' valuation assumption as a comparitive to the current £2 million market cap ?
imabastard
07/4/2009
09:21
ORT-VAC also has very large potential value, the recent success of ORT-VAC as shown by the RNS the other day, could be the another reason we have an approach
hyper al
07/4/2009
09:16
jdb, think before typing!

I worked in validation, I know how much it costs to validate equipment.

My point was that the value of the equipment, training staff, implementing procedures, validating those procedures....would most likely be well over the current market cap.

While each specific new product and related processes would need specific validation, buying Cobra would seem a cheap way of setting up a pilot plant for certain companies. Location would be an issue, but still, transporting it and setting up again would still strike me as a quick and easy option.




Jdb2005 - 7 Apr'09 - 08:20 - 4182 of 4198
d*c - you do talk some rubbish sometimes - their plants are fully validated otherwise they would not have contracts to produce vaccines etc.

Don't attempt to short these !!!

Hyper Al - 7 Apr'09 - 08:23 - 4183 of 4198

Jdb2005

I think he means validating as in valuation of plant would mean that it would cost a couple of £m to buy

the_doctor
07/4/2009
09:09
If they chose to sell off the contents of the company, but not the limited quoted shell, would anybody object then ?
c2b
07/4/2009
09:06
Hyper - Mr & Mrs Dixon are the majority holders then.
jdb2005
07/4/2009
09:04
Thats right.
bones30
07/4/2009
08:58
I think we are up 46% not the 110% advfn suggests
hyper al
07/4/2009
08:56
Jdb2005

This is from cobra website, you can tell they are in serious discussions as this info was updated on their website on 6 April

Mr & Mrs Dixon 43.9% 19,450,000
Pershing Keen Nominees 6.7% 2,983,500
Chase Nominees 6.6% 2,931,675
Vidacos Nominees 5.9% 2,615,213
Cavendish Asset Management 5.1% 2,272,000
Lynchwood Nominees 3.6% 1,590,000

Also

Peter Fothergill 0.7% 326,000
Peter Coleman 0.6% 280,000
Simon Saxby 0.6% 260,000
David Thatcher 0.4% 196,500
Michael Gatenby 0.3% 160,000
Prof Nigel Slater 0.3% 139,000
David Oxlade 0.3% 130,000

hyper al
07/4/2009
08:51
Hyper - when there is talk of potential bid you start looking at who are the majority shareholders in a company. Cobra will not be sold off cheaply.
jdb2005
07/4/2009
08:47
C2B

I agree some long term holders may suffer. But at this price it is a bargain

It happened recently with my investment in Stem. It was sold at a very low price, well at near SP, on the grounds that it was the best thing for the business and employees

hyper al
07/4/2009
08:47
Lets give him the benefit of doubt - as a going concern Cobra must be worth several times its present low valuation.
jdb2005
07/4/2009
08:43
Who is prepared to make a "fuss" if a deal, if one does come, turns out not to benefit all shareholders equally ???

This company has a bad track record on fair dealing.

c2b
07/4/2009
08:43
pegasus59

I think you should at the very least break even.

I have held a share in this for years, yep 1 share. Kept in error. purchased quite a few as soon as I could today.

We must not forget that the staff are also a major asset in this company.

hyper al
07/4/2009
08:34
Jdb - If you read the_doctor again you will realise that is exactly what he meant - i.e. a validated operating plant is worth much more than its bald cost of construction.
boadicea
07/4/2009
08:33
Think this should be at least around the 10p level, 8p at lowest.
hyper al
07/4/2009
08:27
current market cap £1.88m

Think it will be way above that, just for the manufacturing facility, add their business and this is way undervalued!

hyper al
07/4/2009
08:23
Jdb2005

I think he means validating as in valuation of plant would mean that it would cost a couple of £m to buy

hyper al
07/4/2009
08:20
d*c - you do talk some rubbish sometimes - their plants are fully validated otherwise they would not have contracts to produce vaccines etc.

Don't attempt to short these !!!

jdb2005
07/4/2009
08:12
It has always been undervalued.
Just validating the plant would cost a couple of £m!

the_doctor
07/4/2009
08:08
Cobra note about talks with third party re potential bid for the company shows how undervalued it has become.
jdb2005
07/4/2009
08:01
They should have been in talks with a third party for years IMO, given looking for a buyer has always been an obvious option.
the_doctor
07/4/2009
07:56
what is the companies current cash position?
hyper al
07/4/2009
07:53
pmsl - you too have been noted..
whowantstobeamillionaire
Chat Pages: 236  235  234  233  232  231  230  229  228  227  226  225  Older

Your Recent History

Delayed Upgrade Clock